产品详情
靶点信息
JAK1 | JAK2 | JAK3 | ||
11 nM | 18 nM | 155 nM |
In vitro (25°C) | DMSO | 67 mg/mL (161.65 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+40%PEG 300+ 3% Tween80 + ddH2O | 1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.13 mL | 120.63 mL | 241.25 mL |
0.5 mM | 4.83 mL | 24.13 mL | 48.25 mL |
1 mM | 2.41 mL | 12.06 mL | 24.13 mL |
5 mM | 0.48 mL | 2.41 mL | 4.83 mL |
*The above data is based on the productmolecular weight 414.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10263 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 414.5 |
Formula | C23H22N6O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1056634-68-4 |
Synonyms | CYT 11387, Cyt-387 |
SMILES | C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N |
产品资料
产品标签
Product Questions
Product Questions
SGI-1776 (free base)
SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂,在无细胞试验中的IC50为7 nM,选择性是Pim2和Pim3的50倍和10…
Pexidartinib (PLX3397)
Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。
VX-680 (MK-0457, Tozasertib)
VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。
BMS-911543
BMS-911543是一种有效的、选择性JAK2小分子抑制剂。
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。